
USA - NASDAQ:CRTX - US22053A1079 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 88.87M | 90.32M | 78.89M | 39.17M | 12.12M | |||
| Research and Development | 56.73M | 60.80M | 61.31M | 30.21M | 10.09M | |||
| Selling, General, and Administrative Expenses | 32.14M | 29.52M | 17.59M | 8.95M | 2.03M | |||
| Operating Income | -88.87M | -90.32M | -78.89M | -39.17M | -12.12M | |||
| Interest Income/Expense | 465.00K | 620.00K | 2.04M | 2.19M | -360.00K | |||
| Other Income/Expense | -98.00K | -247.00K | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -88.50M | -89.94M | -76.85M | -36.98M | -12.48M | |||
| Income Tax | null | null | null | null | 0 | |||
| Net Income | -88.50M | -89.94M | -76.85M | -36.98M | -12.48M | |||
| EBITDA | -88.58M | -89.97M | -78.56M | -38.98M | -12.07M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.9635371046813073 | -3.026564925361332 | -2.633653187114462 | -1.9432475039411452 | -0.4798154555940023 | |||
| Non GAAP EPS | -2.9699999999999998 | -3.0300000000000002 | -2.63 | -2.9000000000000004 | null | |||
| Statistics | ||||||||
All data in USD